The Impact of Postoperative Renal Function Recovery after Laparoscopic and Robot-Assisted Partial Nephrectomy in Patients with Renal Cell Carcinoma

por Kawase, Kota, Enomoto, Torai, Kawase, Makoto, Takai, Manabu, Kato, Daiki, Fujimoto, Shota, Iinuma, Koji, Nakane, Keita, Kato, Seiichi, Hagiwara, Noriyasu, Uno, Masahiro, Koie, Takuya
Publicado 2022

Effectiveness and Safety of Molecular-Targeted Therapy after Nivolumab Plus Ipilimumab for Advanced or Metastatic Renal Cell Carcinoma: A Multicenter, Retrospective Cohort Study

por Iinuma, Koji, Kameyama, Koji, Taniguchi, Tomoki, Kawada, Kei, Ishida, Takashi, Takagi, Kimiaki, Nagai, Shingo, Enomoto, Torai, Tomioka, Masayuki, Kawase, Makoto, Takeuchi, Shinichi, Kato, Daiki, Takai, Manabu, Nakane, Keita, Koie, Takuya
Publicado 2022

Utility of Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and Systemic Immune Inflammation Index as Prognostic, Predictive Biomarkers in Patients with Metastatic Ren...

por Iinuma, Koji, Enomoto, Torai, Kawada, Kei, Fujimoto, Shota, Ishida, Takashi, Takagi, Kimiaki, Nagai, Shingo, Ito, Hiroki, Kawase, Makoto, Nakai, Chie, Kawase, Kota, Kato, Daiki, Takai, Manabu, Nakane, Keita, Kameyama, Koji, Koie, Takuya
Publicado 2021

Efficacy and Safety of Cabozantinib in Patients with Advanced or Metastatic Renal Cell Carcinoma: A Multicenter Retrospective Cohort Study

por Iinuma, Koji, Tomioka-Inagawa, Risa, Kameyama, Koji, Taniguchi, Tomoki, Kawada, Kei, Ishida, Takashi, Nagai, Shingo, Enomoto, Torai, Ueda, Shota, Kawase, Makoto, Takeuchi, Shinichi, Kawase, Kota, Kato, Daiki, Takai, Manabu, Nakane, Keita, Koie, Takuya
Publicado 2022

Clinical Lymph Node Involvement as a Predictor for Cancer-Specific Survival in Patients with Penile Squamous Cell Cancer

por Kawase, Makoto, Takagi, Kimiaki, Kawada, Kei, Ishida, Takashi, Tomioka, Masayuki, Enomoto, Torai, Fujimoto, Shota, Taniguchi, Tomoki, Ito, Hiroki, Kameyama, Koji, Yamada, Toru, Kawase, Kota, Kato, Daiki, Takai, Manabu, Iinuma, Koji, Nakane, Keita, Koie, Takuya
Publicado 2022

The Efficacy and Safety of Immune Checkpoint Inhibitor and Tyrosine Kinase Inhibitor Combination Therapy for Advanced or Metastatic Renal Cell Carcinoma: A Multicenter Retrospectiv...

por Iinuma, Koji, Yamada, Toyohiro, Kameyama, Koji, Taniguchi, Tomoki, Kawada, Kei, Ishida, Takashi, Nagai, Shingo, Enomoto, Torai, Ueda, Shota, Takagi, Kimiaki, Kawase, Makoto, Takeuchi, Shinichi, Kawase, Kota, Kato, Daiki, Takai, Manabu, Nakane, Keita, Koie, Takuya
Publicado 2023

Oncological Outcomes in Patients with Metastatic Urothelial Carcinoma after Discontinuing Pembrolizumab as a Second-Line Treatment: A Retrospective Multicenter Real-World Cohort St...

por Yamada, Toyohiro, Nakane, Keita, Enomoto, Torai, Tomioka, Masayuki, Taniguchi, Tomoki, Ishida, Takashi, Ozawa, Kaori, Takagi, Kimiaki, Ito, Hiroki, Takeuchi, Shinichi, Kawase, Makoto, Kawase, Kota, Kato, Daiki, Takai, Manabu, Iinuma, Koji, Yokoi, Shigeaki, Nakano, Masahiro, Koie, Takuya
Publicado 2022

The Impact of Neutrophil-to-Lymphocyte Ratio after Two Courses of Pembrolizumab for Oncological Outcomes in Patients with Metastatic Urothelial Carcinoma

por Tomioka-Inagawa, Risa, Nakane, Keita, Enomoto, Torai, Tomioka, Masayuki, Taniguchi, Tomoki, Ishida, Takashi, Ozawa, Kaori, Takagi, Kimiaki, Ito, Hiroki, Takeuchi, Shinichi, Kawase, Makoto, Kawase, Kota, Kato, Daiki, Takai, Manabu, Iinuma, Koji, Yokoi, Shigeaki, Nakano, Masahiro, Koie, Takuya
Publicado 2022